CSCO insider files Form 144 to sell 2,718 RSU shares valued at $185,177
Rhea-AI Filing Summary
Form 144 notice for Cisco Systems, Inc. (CSCO) reporting a proposed sale of 2,718 common shares with an aggregate market value of $185,177.34. The shares are listed outstanding at 3,953,196,953 and the proposed sale is scheduled for 09/11/2025 on NASDAQ. The securities were acquired on 09/10/2025 as RSUs and dividend-equivalent shares from the issuer, with payment noted on 09/10/2025. The filing shows two prior sales in the past three months under a 10b5-1 plan by Deborah Stahlkopf: 9,783 shares on 08/15/2025 for $651,568.34 and 290 shares on 06/12/2025 for $18,638.30. Several filing contact and issuer address fields are blank in the provided text.
Positive
- Timely disclosure of proposed sale under Form 144
- Prior 10b5-1 sales indicate use of structured plans for insider liquidity
Negative
- None.
Insights
TL;DR: Small planned sale of newly acquired RSUs; prior 10b5-1 activity suggests routine insider liquidity rather than a material corporate event.
The proposed sale of 2,718 shares valued at $185,177.34 represents an immaterial fraction of the 3,953,196,953 shares outstanding (approximately 0.00007%). The securities were acquired the day before the intended sale as RSUs and dividend-equivalent shares, and the filer declares no undisclosed material adverse information. Recent 10b5-1 sales by a named insider total 10,073 shares across June and August 2025, indicating ongoing pre-arranged selling activity. Overall, this filing documents routine insider liquidity rather than a change in corporate fundamentals.
TL;DR: Filing appears procedurally compliant; use of RSU issuance followed by timely Form 144 suggests standard insider disposition practices.
The notice reports acquisition by RSU issuance on 09/10/2025 and a proposed sale on 09/11/2025, consistent with insiders selling vested equity. The presence of 10b5-1 sales in the prior three months demonstrates reliance on pre-arranged plans for some dispositions. Several contact and issuer fields in the provided content are incomplete, which limits review of procedural details but does not by itself indicate noncompliance. This is a routine governance disclosure with limited investor impact.